CLB · Core Laboratories Inc. /DE/
Market Cap
$567.13M
Shares
45.88M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$12.36
Open$12.33
Day$12.25–12.43
52W close$9.87–19.67
Avg vol 30d630K
Short int4.3M · 9.3% float · 7.2d
Short vol40%
Last earningsJul 30, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 8 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−18%
below
Price vs 50-day avg
+7%
above
RSI (14)
56
neutral
MACD trend
Negative
52-week position
25%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+16%
trailing
6-month return
−24%
trailing
YTD return
−23%
this year
Relative strength
−38%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $12 › 200d $15 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +31 funds added
Insider flow
Accumulating
Net +$53.9K over 90 days · 0% sells
Short interest
Rising
9.27% of float · ▲ +1.5% MoM · 7.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
186 holders — mid 3-yr range
Squeeze score
72
high risk · 0–100
Fundamentals
Revenue growth
+1%
Y/Y
EPS growth
−5%
Y/Y
Free cash flow
$25.8M
Valuation
P/E 23.8
in line
Balance sheet
$90.3M
net debt
Quant / Vol
risk profile
Volatility
56%
annualized · 1-yr
Max drawdown
−50%
past year
ATR
4.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 29, 2026
Core's third quarter 2026 revenue
· third quarter 2026
Initiated
$128.5M – $135.5M
prior qtr $124.61M
midpoint +5.9% QoQ
Reservoir Description's third quarter 2026 revenue
· third quarter 2026
Initiated
$81M – $84M
Reservoir Description's third quarter 2026 operating income
· third quarter 2026
Initiated
$5.5M – $7.9M
Production Enhancement's third quarter revenue
· third quarter 2026
Initiated
$47.5M – $51.5M
EPS for the third quarter of 2026
· third quarter 2026
Initiated
$0.12 – $0.20
prior qtr $0.13
midpoint +23.1% QoQ
Production Enhancement's third quarter operating income
· third quarter 2026
Initiated
$4.8M – $6.9M
Core's third quarter 2026 operating income
· third quarter 2026
Initiated
$10.5M – $15M
Prior guidance
period ended
· from the 8-K filed Apr 29, 2026
Reservoir Description's second quarter 2026 operating income
· second quarter 2026
$3.5M – $5.38M
Core's second quarter 2026 revenue
· second quarter 2026
$123M – $131M
Core's second quarter 2026 operating income
· second quarter 2026
$6.4M – $10.2M
Production Enhancement's second quarter operating income
· second quarter 2026
$2.8M – $4.7M
EPS for the second quarter of 2026
· second quarter 2026
$0.06 – $0.12
Guided vs delivered
· last 8 settled
Core's second quarter 2026 revenue
second quarter 2026
guided $123M – $131M
$124.61M
In line
EPS for the second quarter of 2026
second quarter 2026
guided $0.06 – $0.12
$0.13
Beat +44.4%
Core’s fourth quarter 2025 revenue
fourth quarter 2025
guided $132M – $136M
$138.26M
Beat +3.2%
Core's third quarter 2025 revenue
third quarter 2025
guided $127.5M – $134.5M
$134.52M
Beat +2.7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−18%
Bearish
Price vs 50-day avg
+7%
Bullish
RSI (14)
56
Neutral
MACD trend
Negative
Bearish
52-week position
25%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $12 › 200d $15 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +31 funds added
Insider flow
Accumulating
Net +$53.9K over 90 days · 0% sells
Short interest
Rising
9.27% of float · ▲ +1.5% MoM · 7.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
186 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $10
Now $12 · 25%
Range high $20
vs 200-day avg -18%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Debt to Adjusted EBITDA ratio non-GAAP | 1.3 | Three Months Ended June 30, 2026 filing | — |
| Debt to EBITDA ratio | 1.48 | Three Months Ended June 30, 2026 filing | — |
| Diluted earnings per share, ex-items non-GAAP | $0.17 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Production Enhancement operating margins, ex-items non-GAAP | 12% | Q2 2026 | — |
| ROIC non-GAAP | 8.3% | Q2 2026 | — |
|
|
|||
| Shares of common stock repurchased | 214,712 | Q2 2026 | — |
|
|
|||
| Free cash flow non-GAAP | $517K | Q1 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities $3.97M
-$3.45M Capital expenditures - operations
= Free cash flow $517K
|
|||
| Net Income (Loss) Attributable to Core Laboratories Inc., ex-items non-GAAP | $2.75M | Q1 2026 | — |
|
|
|||
| Operating income, ex-items non-GAAP | $6.6M | Q1 2026 | — |
| Production Enhancement operating income, ex-items non-GAAP | $1.82M | Q1 2026 | — |
| Reservoir Description operating income, ex-items non-GAAP | $4.81M | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Oil & Gas Equipment & Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLB
this stock
Core Laboratories Inc. /DE/
|
$567.13M | -22.9% | +0.5% | 23.8 | 9.3% |
|
SLB
Slb Limited/Nv
|
$85.09B | +49.4% | +9.5% | 28.0 | 3.7% |
|
BKR
Baker Hughes Co
|
$63.08B | +37.0% | -0.3% | — | 2.4% |
|
HAL
Halliburton Co
|
$30.14B | +28.0% | +22.5% | — | 3.7% |
|
FTI
TechnipFMC plc
|
$29.74B | +70.2% | +9.4% | 26.4 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLB | -1.3% | +16.2% | -24.3% | +16.2% | -22.9% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -1.8% | +13.2% | -37.7% | +13.2% | -35.7% |
Capital returns
Latest dividend
$0.01
/ share · ex Aug 10, 2026
Paid (TTM)
$0.04
/ share · 4 payouts
Dividend yield (TTM, derived)
0.32%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.